WIRobotics announced on May 14, 2026 that it has secured approximately KRW 95 billion (about USD 68 million) in Series B funding to accelerate development of ALLEX, its general-purpose humanoid robot platform.[^1] The round, per the company's release, was led by JB Investment with participation from InterVest, Hana Ventures, Smilegate Investment, SBVA, NH Investment & Securities, Company K Partners, GU Investment and FuturePlay.[^1]
For TheMimic readers, the more useful question is not the headline number but what the round repositions. WIRobotics has, until now, been read primarily as a Korean wearable-robotics company. The Series B explicitly funds a transition from wearables to an integrated humanoid platform — a category where Korea has not yet had a globally visible entrant on the scale of Figure, 1X, Apptronik, Unitree or Tesla Optimus.
The short version: WIRobotics announced a roughly KRW 95 billion (about USD 68 million) Series B on May 14, 2026, led by JB Investment, to move from wearables into its ALLEX humanoid platform. It is a credibility event, not a capability one: only ALLEX's upper body has been unveiled, with no independent benchmarks yet.
What was announced
The funding details, per the company's distributed PR Newswire release, are as follows.[^1]
- Size: approximately KRW 95 billion (about USD 68 million).
- Lead: JB Investment.
- Participants: InterVest, Hana Ventures, Smilegate Investment, SBVA, NH Investment & Securities, Company K Partners, GU Investment and FuturePlay.
- Prior round: follows a KRW 13 billion Series A closed in March 2024.[^1]
- Use of funds: advance humanoid commercialization and expand from wearables to integrated robotics platforms, per WIRobotics.[^1]
Korean trade publication The Elec, in a May 15, 2026 report, corroborates the KRW 95 billion size and the follow-on framing relative to the March 2024 Series A.[^2] Pulse 2.0's coverage of the same release likewise reports the round size, the lead investor and the participant list, and notes that the company is developing ALLEX and is collaborating with NVIDIA and AWS on physical AI work.[^3]
ALLEX: the platform behind the round
The Series B is being raised against a specific product story. WIRobotics' release describes ALLEX as a humanoid robot platform under development "to achieve human-level manipulation intelligence."[^1] The company says it is building ALLEX using technologies it has developed for understanding and augmenting human movement — a lineage that traces back to its wearable robotics work.[^1]
A background release, dated August 18, 2025, says WIRobotics unveiled the upper body of its first general-purpose humanoid robot ALLEX at the Robot Innovation Hub at KOREATECH.[^4] In that release, the company claims human-like whole-body force sensing and compliance across arms, fingers and waist, a high-degree-of-freedom compliant hand, a low-friction backdrivable arm, and a gravity-compensated upper body.[^4] Those are company claims about a development platform, not independently verified benchmarks, and the August 2025 reveal covered the upper body rather than a complete bipedal system.
The release also says WIRobotics established Korea's first Wearable Robot Gait Training Center and opened the Robot Innovation Hub in June 2024.[^4] That infrastructure is part of what the Series B narrative is framing as a credible path from wearable engineering into a full humanoid platform.
Physical AI partnerships
Two infrastructure-side relationships are central to the Series B framing. According to WIRobotics' release, the company was selected for NVIDIA's Physical AI Fellowship and is collaborating with AWS and NVIDIA on physical AI technologies, including joint research and proofs-of-concept around humanoid robot intelligence.[^1] Pulse 2.0 repeats the same characterization.[^3]
Selection into a vendor program and announced collaborations are real signals about access to compute, models and engineering relationships. They are not the same as a deployed product, a customer-validated capability, or independent benchmarks. The honest read is that WIRobotics has positioned itself inside the same physical-AI tooling layer that several other 2026 humanoid efforts are organizing around. For broader context on how Asian players are organizing this push, see TheMimic's coverage of Asia's physical AI offensive.
Company-stated commercialization plan
Korea Biomedical Review, citing WIRobotics directly, reports that the company plans to begin selling ALLEX to AI companies, global big-tech firms and research institutions in Q4 2026, with an annual production capacity target of more than 300 units by the end of 2027.[^5] KBR reports the funding as 95 billion won and converts it to approximately USD 63 million — slightly different from the ~USD 68 million in the company's distributed release, reflecting different exchange-rate snapshots rather than a different round.[^1][^5]
KBR also quotes the company as saying: "The highest priority is ALLEX development and building a mass-production system," and "We want to quickly build mass production and a global supply chain."[^5]
Those are company-stated plans, not proven commercial availability. A Q4 2026 sales target and a 300-units-per-year capacity goal by end of 2027 are useful as a stated roadmap; they are not evidence that ALLEX will ship at that volume, at any specific price, or with the reliability needed for the buyer segments WIRobotics is naming. Humanoid platforms have historically slipped on exactly these milestones, and outside reporting has not independently verified production readiness.
Why this matters: Korea in the humanoid platform race
Most of the visible 2025-2026 humanoid platform race has been framed around U.S. and Chinese players — Figure, 1X, Apptronik, Tesla Optimus, Unitree, AgiBot, XPeng, UBTech, and a long tail of foundation-model bets like Physical Intelligence and Genesis AI. Korea has strong industrial robotics, mobility robotics and wearable robotics, but WIRobotics is now trying to move that base into a general-purpose humanoid platform aimed at AI-company, big-tech and research-institution buyers.[^5]
WIRobotics' Series B is a credible attempt to make that transition visible. The investor list reads as a syndicate of mainstream Korean institutional capital — JB Investment, InterVest, Hana Ventures, Smilegate Investment, SBVA, NH Investment & Securities, Company K Partners, GU Investment and FuturePlay — backing a wearables-origin team that is now explicitly chasing an integrated humanoid platform.[^1] That syndication pattern, combined with the NVIDIA and AWS positioning, is the shape of a platform bet, not a one-off industrial automation deal.
It also fits a recognizable 2026 pattern. The market is funding three rough clusters in parallel: humanoid product platforms, vertically scoped industrial robotics, and physical-AI foundation models. For a TheMimic walk-through of where the major humanoid platforms stand, see the humanoid race in 2026. For the foundation-model side, see Physical Intelligence's reported $1B round. WIRobotics lands in the first cluster as one of the clearer Korean attempts to compete with a general-purpose humanoid platform rather than only wearable or industrial-assist robots.
What this round does not prove
A ~USD 68 million Series B is a credibility event, not a capability event. From the available source material, the round does not establish:
- A shipping general-purpose humanoid product.
- Independently verified benchmarks for ALLEX's manipulation, mobility, autonomy, reliability or safety.
- A named external customer, paid pilot, or deployment with disclosed scope.
- Realized production volume, unit economics, or pricing.
- Confirmation, outside of company statements, that the Q4 2026 sales window or the 300-units-per-year 2027 capacity target will be met.[^5]
That is normal for a humanoid-platform company at this stage. It is also why TheMimic does not treat funding rounds as evidence of operational progress. For the broader argument about the distance between demo-grade footage and field-grade work, see from demo to deployment.
What TheMimic will watch next
Concrete things that would move WIRobotics from "well-funded Korean humanoid bet" to "platform with demonstrated traction":
- A complete ALLEX system reveal, going beyond the August 2025 upper-body unveil to a full bipedal platform with disclosed specifications.[^4]
- Independent third-party reporting or benchmarking of ALLEX manipulation, mobility or reliability, separate from company-distributed materials.
- A named first customer in the AI-company, big-tech or research-institution buyer set that WIRobotics has identified, with scope and timing.[^5]
- Production milestones that test the company-stated path to 300+ units per year by end of 2027, including facility, supplier and yield disclosures.[^5]
- Concrete output from the NVIDIA Physical AI Fellowship and AWS collaborations — co-published research, demonstrated capabilities, or shared infrastructure beyond a relationship announcement.[^1]
Until at least some of those land, the responsible read is the one the public sources support: WIRobotics is a Korean wearable-robotics company that has now raised institutional capital at humanoid-platform scale to attempt a transition into a general-purpose humanoid product, with infrastructure-side partnerships in place and a company-stated commercialization plan that has not yet been externally validated.
Directory update notes
For TheMimic curator/importer:
- Action: add.
- Entity type: humanoid robotics company / wearable-robotics origin.
- Company: WIRobotics (Korea).
- Status: privately held; announced Series B of approximately KRW 95 billion (about USD 68 million) on May 14, 2026, led by JB Investment, per the company.[^1] Follow-on after KRW 13 billion Series A in March 2024.[^1][^2]
- Investors of record: JB Investment (lead, Series B); InterVest, Hana Ventures, Smilegate Investment, SBVA, NH Investment & Securities, Company K Partners, GU Investment, FuturePlay (Series B participants).[^1]
- Platform: ALLEX, general-purpose humanoid robot platform under development; upper body unveiled August 18, 2025 at Robot Innovation Hub, KOREATECH.[^1][^4]
- Stated commercialization plan: company says it plans to begin selling ALLEX to AI companies, global big-tech firms and research institutions in Q4 2026, with annual production capacity target of 300+ units by end of 2027.[^5]
- Partnerships: selected for NVIDIA's Physical AI Fellowship; collaborating with AWS and NVIDIA on physical AI technologies, per the company.[^1][^3]
- Confidence: high for the funding event, investor list and partnership selections; medium for ALLEX's claimed hardware characteristics (company claims, not independently verified); low for commercial readiness, production volume and external traction.
- Last verified: 2026-05-16.
FAQ
How much did WIRobotics raise in its Series B?
WIRobotics announced approximately KRW 95 billion (about USD 68 million) in Series B funding on May 14, 2026, per its distributed release.[^1] Korea Biomedical Review reports the same KRW figure and converts it to approximately USD 63 million using a different exchange-rate snapshot.[^5] Both reflect the same round.
Who led the WIRobotics Series B?
JB Investment led the round, per the company's release.[^1] Participants included InterVest, Hana Ventures, Smilegate Investment, SBVA, NH Investment & Securities, Company K Partners, GU Investment and FuturePlay.[^1]
What is ALLEX?
ALLEX is WIRobotics' general-purpose humanoid robot platform, described by the company as under development to achieve human-level manipulation intelligence.[^1] The upper body of ALLEX was unveiled on August 18, 2025 at the Robot Innovation Hub at KOREATECH.[^4]
Is ALLEX shipping or available to buy?
No. WIRobotics has told Korea Biomedical Review that it plans to begin selling ALLEX to AI companies, global big-tech firms and research institutions in Q4 2026, with an annual production capacity target of more than 300 units by end of 2027.[^5] These are company-stated plans, not confirmed availability.
What is WIRobotics' relationship with NVIDIA and AWS?
According to WIRobotics, the company was selected for NVIDIA's Physical AI Fellowship and is collaborating with AWS and NVIDIA on physical AI technologies, including joint research and proofs-of-concept around humanoid robot intelligence.[^1] Pulse 2.0 reports the same.[^3]
How does WIRobotics fit the broader 2026 humanoid landscape?
WIRobotics is the first Korean humanoid-platform contender in 2026 to raise institutional capital at a scale comparable to the more visible U.S. and Chinese humanoid efforts. It sits in the humanoid product-platform cluster, alongside companies covered in the humanoid race in 2026, and complements broader Asian physical-AI momentum described in Asia's physical AI offensive.
Sources
[^1]: WIRobotics, "WIRobotics Secures Approximately KRW 100 Billion ($68 Million USD) Series B Funding," PR Newswire, May 14, 2026, https://www.prnewswire.com/news-releases/wirobotics-secures-approximately-krw-100-billion-usd-68-million-series-b-funding-302772164.html
[^2]: The Elec, WIRobotics 95 billion won Series B report, May 15, 2026, https://www.thelec.net/news/articleView.html?idxno=10507
[^3]: Pulse 2.0, "WIRobotics: About $68 Million Series B Raised To Advance Humanoid Robotics And Physical AI," https://pulse2.com/wirobotics-about-68-million-series-b-raised-to-advance-humanoid-robotics-and-physical-ai/
[^4]: WIRobotics, "WIRobotics Unveils ALLEX, a General-Purpose Humanoid with Human-Like Responsiveness," PR Newswire, August 18, 2025, https://www.prnewswire.com/news-releases/wirobotics-unveils-allex-a-general-purpose-humanoid-with-human-like-responsiveness-302532078.html
[^5]: Korea Biomedical Review, WIRobotics ALLEX commercialization plan report, https://www.koreabiomed.com/news/articleView.html?idxno=31677
Published by themimic.io — tracking the humanoid robotics industry without the hype.